Likewise, the gene codifying for MMP2 has been identified as a novel oncogene in colorectal cancer [128], while increased MMP-2 activity is involved in an essential step for the metastatic progression of most cancers [129] and also linked with a poor prognosis in multiple tumors, including glioma [130]. This evidence concerns the gene MMP2 and central nervous system cancer.